心不全で入院する前の体重変化のパターン
Sarwat I Chaudhry1, Yongfei Wang, John Concato
1Department of Internal Medicine, Section of General Medicine, Yale School of Medicine, New Haven, CT 06520, USA. sarwat.chaudhry@yale.edu
Circulation
|September 12, 2007
まとめ
心不全で入院する前の体重増加は,入院の少なくとも1週間前に始まります. 心不全患者における毎日の体重のモニタリングは,介入のための高リスク期間を特定することができます.
科学分野:
- 心臓病学 心臓病学
- 医療モニタリング
- 公衆衛生は公衆衛生である.
背景:
- 体重増加は,疾患管理における心不全不補償の認識されたマーカーです.
- 心不全患者の体重変化と入院リスクの正確な関係に関するデータは限られている.
研究 の 目的:
- 体重の変化と,心不全の患者の間近の入院リスクとの関連を定量化するために.
- 体重増加と心不全の入院の間の時間的関係を特定するために.
主な方法:
- 家でのモニタリングシステムからのデータを用いて,内蔵された症例対照研究が行われました.
- 心不全で入院した134人の症例患者は,134人の対照患者とマッチングされた.
- 分析は,モニタリングシステムへの登録と比較した重量変化に焦点を当てた.
主要な成果:
- 症例患者は,入院前約30日 (P<0.001) から徐々に体重が増加することが示されました.
- >2-5ポンド,>5-10ポンド,および>10ポンドの体重増加は,入院の確率が大幅に増加したものと関連していました (ORs 2.77, 4.46, 7.65).
- 体重パターンは,入院前の1週間で著しく異なっていた.
結論:
- 体重増加は,心不全の入院と関連しており,入院は少なくとも1週間前に始まっています.
- 日々の体重モニタリングは,入院を必要とする不補償性心不全を予防するための積極的な介入のための高リスク期間を特定することができます.
関連する概念動画
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:29Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.